| JYSB2000001 | 注射用阿替普酶 | alteplase | Lyophilized | Biological Products | Supplementary Application | 2020-02-03 | 勃林格殷格翰(中国)投资有限公司 | Boehringer Ingelheim (China) Investment Co Ltd;Boehringer Ingelheim Pharma Gmbh & Co KG | Certificate Issued | 2021-08-31 | view |
| JYSB2000002 | 注射用阿替普酶 | alteplase | Lyophilized | Biological Products | Supplementary Application | 2020-02-03 | 勃林格殷格翰(中国)投资有限公司 | Boehringer Ingelheim (China) Investment Co Ltd;Boehringer Ingelheim Pharma Gmbh & Co KG | Certificate Issued | 2021-08-31 | view |
| JYSB1800098 | 注射用阿替普酶 | alteplase | Lyophilized | Biological Products | Supplementary Application | 2018-05-14 | 勃林格殷格翰(中国)投资有限公司 | Boehringer Ingelheim (China) Investment Co Ltd;Boehringer Ingelheim Pharma Gmbh & Co KG | Certificate Issued | 2021-02-02 | view |
| JYSB1800096 | 注射用阿替普酶 | alteplase | Lyophilized | Biological Products | Supplementary Application | 2018-05-14 | 勃林格殷格翰(中国)投资有限公司 | Boehringer Ingelheim (China) Investment Co Ltd;Boehringer Ingelheim Pharma Gmbh & Co KG | Certificate Issued | 2021-02-02 | view |
| JYHZ2000026 | 美洛昔康注射液 | meloxicam | Injection | Chemical Drugs | License Renew | 2020-03-11 | 勃林格殷格翰(中国)投资有限公司 | Boehringer Ingelheim (China) Investment Co Ltd;Boehringer Ingelheim France;Boehringer Ingelheim Espana SA | Certificate Issued | 2020-07-31 | view |
| JYHZ2000027 | 美洛昔康注射液 | meloxicam | Injection | Chemical Drugs | License Renew | 2020-02-25 | 勃林格殷格翰(中国)投资有限公司 | Boehringer Ingelheim (China) Investment Co Ltd;Boehringer Ingelheim France;Boehringer Ingelheim Espana SA | Certificate Issued | 2020-07-31 | view |
| JYHB2000816 | 美洛昔康注射液 | meloxicam | Injection | Chemical Drugs | Supplementary Application | 2020-06-12 | 勃林格殷格翰(中国)投资有限公司 | Boehringer Ingelheim (China) Investment Co Ltd;Boehringer Ingelheim France;Boehringer Ingelheim Espana SA | Filed | 2020-06-19 | view |
| JYSB1900366 | 注射用阿替普酶 | alteplase | Lyophilized | Biological Products | Supplementary Application | 2020-01-03 | 勃林格殷格翰(中国)投资有限公司 | Boehringer Ingelheim (China) Investment Co Ltd;Boehringer Ingelheim Pharma Gmbh & Co KG | Filed | 2020-01-08 | view |
| JYSB1900367 | 注射用阿替普酶 | alteplase | Lyophilized | Biological Products | Supplementary Application | 2020-01-03 | 勃林格殷格翰(中国)投资有限公司 | Boehringer Ingelheim (China) Investment Co Ltd;Boehringer Ingelheim Pharma Gmbh & Co KG | Filed | 2020-01-08 | view |
| JYSB1700169 | 注射用阿替普酶 | alteplase | Lyophilized | Biological Products | Supplementary Application | 2017-10-20 | 勃林格殷格翰(中国)投资有限公司 | Boehringer Ingelheim (China) Investment Co Ltd;Boehringer Ingelheim Pharma Gmbh & Co KG | Certificate Issued | 2019-12-23 | view |
| JYSB1700170 | 注射用阿替普酶 | alteplase | Lyophilized | Biological Products | Supplementary Application | 2017-10-20 | 勃林格殷格翰(中国)投资有限公司 | Boehringer Ingelheim (China) Investment Co Ltd;Boehringer Ingelheim Pharma Gmbh & Co KG | Certificate Issued | 2019-12-23 | view |
| JYSB1900204 | 注射用阿替普酶 | alteplase | Lyophilized | Biological Products | Supplementary Application | 2019-09-18 | 勃林格殷格翰(中国)投资有限公司 | Boehringer Ingelheim (China) Investment Co Ltd;Boehringer Ingelheim Pharma Gmbh & Co KG | Certificate Issued | 2019-12-05 | view |
| JYSB1900205 | 注射用阿替普酶 | alteplase | Lyophilized | Biological Products | Supplementary Application | 2019-09-18 | 勃林格殷格翰(中国)投资有限公司 | Boehringer Ingelheim (China) Investment Co Ltd;Boehringer Ingelheim Pharma Gmbh & Co KG | Certificate Issued | 2019-12-05 | view |
| JYSB1800119 | 注射用阿替普酶 | alteplase | Lyophilized | Biological Products | Supplementary Application | 2018-06-04 | 勃林格殷格翰(中国)投资有限公司 | Boehringer Ingelheim (China) Investment Co Ltd;Boehringer Ingelheim Pharma Gmbh & Co KG | Certificate Issued | 2019-11-28 | view |
| JYSB1800118 | 注射用阿替普酶 | alteplase | Lyophilized | Biological Products | Supplementary Application | 2018-06-04 | 勃林格殷格翰(中国)投资有限公司 | Boehringer Ingelheim (China) Investment Co Ltd;Boehringer Ingelheim Pharma Gmbh & Co KG | Certificate Issued | 2019-11-28 | view |
| JYSB1800001 | 注射用阿替普酶 | alteplase | Lyophilized | Biological Products | Supplementary Application | 2018-01-26 | 勃林格殷格翰(中国)投资有限公司 | Boehringer Ingelheim (China) Investment Co Ltd;Boehringer Ingelheim Pharma Gmbh & Co KG | Certificate Issued | 2019-08-05 | view |
| JYSB1800002 | 注射用阿替普酶 | alteplase | Lyophilized | Biological Products | Supplementary Application | 2018-01-26 | 勃林格殷格翰(中国)投资有限公司 | Boehringer Ingelheim (China) Investment Co Ltd;Boehringer Ingelheim Pharma Gmbh & Co KG | Certificate Issued | 2019-08-05 | view |
| JYSB1800095 | 注射用阿替普酶 | alteplase | Lyophilized | Biological Products | Supplementary Application | 2018-05-14 | 勃林格殷格翰(中国)投资有限公司 | Boehringer Ingelheim (China) Investment Co Ltd;Boehringer Ingelheim Pharma Gmbh & Co KG | Certificate Issued | 2018-09-19 | view |
| JYSB1800099 | 注射用阿替普酶 | alteplase | Lyophilized | Biological Products | Supplementary Application | 2018-05-14 | 勃林格殷格翰(中国)投资有限公司 | Boehringer Ingelheim (China) Investment Co Ltd;Boehringer Ingelheim Pharma Gmbh & Co KG | Certificate Issued | 2018-09-19 | view |
| JXHL1600051 | 尼达尼布软胶囊 | nintedanib | Soft capsules | Chemical Drugs | Import Drug Application | 2016-05-10 | 勃林格殷格翰(中国)投资有限公司 | Boehringer Ingelheim (China) Investment Co Ltd;Boehringer Ingelheim Pty Ltd | Certificate Issued | 2018-03-26 | view |
